Global Virtual Screening for Drug Discovery Market 2024 by Company, Regions, Type and Application, Forecast to 2030

1 Market Overview

• 1.1 Product Overview and Scope
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Classification of Virtual Screening for Drug Discovery by Type
  • 1.3.1 Overview: Global Virtual Screening for Drug Discovery Market Size by Type: 2019 Versus 2023 Versus 2030
  • 1.3.2 Global Virtual Screening for Drug Discovery Consumption Value Market Share by Type in 2023
  • 1.3.3 Structure-based Virtual Screening (SBVS)
  • 1.3.4 Ligand-based Virtual Screening (LBVS)
  • 1.3.5 Hybrid Methods
• 1.4 Global Virtual Screening for Drug Discovery Market by Application
  • 1.4.1 Overview: Global Virtual Screening for Drug Discovery Market Size by Application: 2019 Versus 2023 Versus 2030
  • 1.4.2 Pharmaceutical Company
  • 1.4.3 Universities and Research Institutions
  • 1.4.4 Others
• 1.5 Global Virtual Screening for Drug Discovery Market Size & Forecast
• 1.6 Global Virtual Screening for Drug Discovery Market Size and Forecast by Region
  • 1.6.1 Global Virtual Screening for Drug Discovery Market Size by Region: 2019 VS 2023 VS 2030
  • 1.6.2 Global Virtual Screening for Drug Discovery Market Size by Region, (2019-2030)
  • 1.6.3 North America Virtual Screening for Drug Discovery Market Size and Prospect (2019-2030)
  • 1.6.4 Europe Virtual Screening for Drug Discovery Market Size and Prospect (2019-2030)
  • 1.6.5 Asia-Pacific Virtual Screening for Drug Discovery Market Size and Prospect (2019-2030)
  • 1.6.6 South America Virtual Screening for Drug Discovery Market Size and Prospect (2019-2030)
  • 1.6.7 Middle East & Africa Virtual Screening for Drug Discovery Market Size and Prospect (2019-2030)

2 Company Profiles

• 2.1 MedChemExpress
  • 2.1.1 MedChemExpress Details
  • 2.1.2 MedChemExpress Major Business
  • 2.1.3 MedChemExpress Virtual Screening for Drug Discovery Product and Solutions
  • 2.1.4 MedChemExpress Virtual Screening for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
  • 2.1.5 MedChemExpress Recent Developments and Future Plans
• 2.2 TargetMol
  • 2.2.1 TargetMol Details
  • 2.2.2 TargetMol Major Business
  • 2.2.3 TargetMol Virtual Screening for Drug Discovery Product and Solutions
  • 2.2.4 TargetMol Virtual Screening for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
  • 2.2.5 TargetMol Recent Developments and Future Plans
• 2.3 OpenEye Scientific
  • 2.3.1 OpenEye Scientific Details
  • 2.3.2 OpenEye Scientific Major Business
  • 2.3.3 OpenEye Scientific Virtual Screening for Drug Discovery Product and Solutions
  • 2.3.4 OpenEye Scientific Virtual Screening for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
  • 2.3.5 OpenEye Scientific Recent Developments and Future Plans
• 2.4 Eurofins Discovery
  • 2.4.1 Eurofins Discovery Details
  • 2.4.2 Eurofins Discovery Major Business
  • 2.4.3 Eurofins Discovery Virtual Screening for Drug Discovery Product and Solutions
  • 2.4.4 Eurofins Discovery Virtual Screening for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
  • 2.4.5 Eurofins Discovery Recent Developments and Future Plans
• 2.5 Sygnature Discovery
  • 2.5.1 Sygnature Discovery Details
  • 2.5.2 Sygnature Discovery Major Business
  • 2.5.3 Sygnature Discovery Virtual Screening for Drug Discovery Product and Solutions
  • 2.5.4 Sygnature Discovery Virtual Screening for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
  • 2.5.5 Sygnature Discovery Recent Developments and Future Plans
• 2.6 Jubilant Biosys
  • 2.6.1 Jubilant Biosys Details
  • 2.6.2 Jubilant Biosys Major Business
  • 2.6.3 Jubilant Biosys Virtual Screening for Drug Discovery Product and Solutions
  • 2.6.4 Jubilant Biosys Virtual Screening for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
  • 2.6.5 Jubilant Biosys Recent Developments and Future Plans
• 2.7 Schrödinger, Inc.
  • 2.7.1 Schrödinger, Inc. Details
  • 2.7.2 Schrödinger, Inc. Major Business
  • 2.7.3 Schrödinger, Inc. Virtual Screening for Drug Discovery Product and Solutions
  • 2.7.4 Schrödinger, Inc. Virtual Screening for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
  • 2.7.5 Schrödinger, Inc. Recent Developments and Future Plans
• 2.8 Cresset Group
  • 2.8.1 Cresset Group Details
  • 2.8.2 Cresset Group Major Business
  • 2.8.3 Cresset Group Virtual Screening for Drug Discovery Product and Solutions
  • 2.8.4 Cresset Group Virtual Screening for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
  • 2.8.5 Cresset Group Recent Developments and Future Plans
• 2.9 ComputaBio
  • 2.9.1 ComputaBio Details
  • 2.9.2 ComputaBio Major Business
  • 2.9.3 ComputaBio Virtual Screening for Drug Discovery Product and Solutions
  • 2.9.4 ComputaBio Virtual Screening for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
  • 2.9.5 ComputaBio Recent Developments and Future Plans
• 2.10 Profacgen
  • 2.10.1 Profacgen Details
  • 2.10.2 Profacgen Major Business
  • 2.10.3 Profacgen Virtual Screening for Drug Discovery Product and Solutions
  • 2.10.4 Profacgen Virtual Screening for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
  • 2.10.5 Profacgen Recent Developments and Future Plans
• 2.11 CD ComputaBio
  • 2.11.1 CD ComputaBio Details
  • 2.11.2 CD ComputaBio Major Business
  • 2.11.3 CD ComputaBio Virtual Screening for Drug Discovery Product and Solutions
  • 2.11.4 CD ComputaBio Virtual Screening for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
  • 2.11.5 CD ComputaBio Recent Developments and Future Plans
• 2.12 Creative Biolabs
  • 2.12.1 Creative Biolabs Details
  • 2.12.2 Creative Biolabs Major Business
  • 2.12.3 Creative Biolabs Virtual Screening for Drug Discovery Product and Solutions
  • 2.12.4 Creative Biolabs Virtual Screening for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
  • 2.12.5 Creative Biolabs Recent Developments and Future Plans
• 2.13 BOC Sciences
  • 2.13.1 BOC Sciences Details
  • 2.13.2 BOC Sciences Major Business
  • 2.13.3 BOC Sciences Virtual Screening for Drug Discovery Product and Solutions
  • 2.13.4 BOC Sciences Virtual Screening for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
  • 2.13.5 BOC Sciences Recent Developments and Future Plans
• 2.14 CKTTDB
  • 2.14.1 CKTTDB Details
  • 2.14.2 CKTTDB Major Business
  • 2.14.3 CKTTDB Virtual Screening for Drug Discovery Product and Solutions
  • 2.14.4 CKTTDB Virtual Screening for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
  • 2.14.5 CKTTDB Recent Developments and Future Plans
• 2.15 HitGen
  • 2.15.1 HitGen Details
  • 2.15.2 HitGen Major Business
  • 2.15.3 HitGen Virtual Screening for Drug Discovery Product and Solutions
  • 2.15.4 HitGen Virtual Screening for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
  • 2.15.5 HitGen Recent Developments and Future Plans
• 2.16 WuXi AppTec
  • 2.16.1 WuXi AppTec Details
  • 2.16.2 WuXi AppTec Major Business
  • 2.16.3 WuXi AppTec Virtual Screening for Drug Discovery Product and Solutions
  • 2.16.4 WuXi AppTec Virtual Screening for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
  • 2.16.5 WuXi AppTec Recent Developments and Future Plans
• 2.17 LeadBuilder
  • 2.17.1 LeadBuilder Details
  • 2.17.2 LeadBuilder Major Business
  • 2.17.3 LeadBuilder Virtual Screening for Drug Discovery Product and Solutions
  • 2.17.4 LeadBuilder Virtual Screening for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
  • 2.17.5 LeadBuilder Recent Developments and Future Plans
• 2.18 CSNpharm
  • 2.18.1 CSNpharm Details
  • 2.18.2 CSNpharm Major Business
  • 2.18.3 CSNpharm Virtual Screening for Drug Discovery Product and Solutions
  • 2.18.4 CSNpharm Virtual Screening for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
  • 2.18.5 CSNpharm Recent Developments and Future Plans
• 2.19 ChemNavigator
  • 2.19.1 ChemNavigator Details
  • 2.19.2 ChemNavigator Major Business
  • 2.19.3 ChemNavigator Virtual Screening for Drug Discovery Product and Solutions
  • 2.19.4 ChemNavigator Virtual Screening for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
  • 2.19.5 ChemNavigator Recent Developments and Future Plans

3 Market Competition, by Players

• 3.1 Global Virtual Screening for Drug Discovery Revenue and Share by Players (2019-2024)
• 3.2 Market Share Analysis (2023)
  • 3.2.1 Market Share of Virtual Screening for Drug Discovery by Company Revenue
  • 3.2.2 Top 3 Virtual Screening for Drug Discovery Players Market Share in 2023
  • 3.2.3 Top 6 Virtual Screening for Drug Discovery Players Market Share in 2023
• 3.3 Virtual Screening for Drug Discovery Market: Overall Company Footprint Analysis
  • 3.3.1 Virtual Screening for Drug Discovery Market: Region Footprint
  • 3.3.2 Virtual Screening for Drug Discovery Market: Company Product Type Footprint
  • 3.3.3 Virtual Screening for Drug Discovery Market: Company Product Application Footprint
• 3.4 New Market Entrants and Barriers to Market Entry
• 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

• 4.1 Global Virtual Screening for Drug Discovery Consumption Value and Market Share by Type (2019-2024)
• 4.2 Global Virtual Screening for Drug Discovery Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

• 5.1 Global Virtual Screening for Drug Discovery Consumption Value Market Share by Application (2019-2024)
• 5.2 Global Virtual Screening for Drug Discovery Market Forecast by Application (2025-2030)

6 North America

• 6.1 North America Virtual Screening for Drug Discovery Consumption Value by Type (2019-2030)
• 6.2 North America Virtual Screening for Drug Discovery Market Size by Application (2019-2030)
• 6.3 North America Virtual Screening for Drug Discovery Market Size by Country
  • 6.3.1 North America Virtual Screening for Drug Discovery Consumption Value by Country (2019-2030)
  • 6.3.2 United States Virtual Screening for Drug Discovery Market Size and Forecast (2019-2030)
  • 6.3.3 Canada Virtual Screening for Drug Discovery Market Size and Forecast (2019-2030)
  • 6.3.4 Mexico Virtual Screening for Drug Discovery Market Size and Forecast (2019-2030)

7 Europe

• 7.1 Europe Virtual Screening for Drug Discovery Consumption Value by Type (2019-2030)
• 7.2 Europe Virtual Screening for Drug Discovery Consumption Value by Application (2019-2030)
• 7.3 Europe Virtual Screening for Drug Discovery Market Size by Country
  • 7.3.1 Europe Virtual Screening for Drug Discovery Consumption Value by Country (2019-2030)
  • 7.3.2 Germany Virtual Screening for Drug Discovery Market Size and Forecast (2019-2030)
  • 7.3.3 France Virtual Screening for Drug Discovery Market Size and Forecast (2019-2030)
  • 7.3.4 United Kingdom Virtual Screening for Drug Discovery Market Size and Forecast (2019-2030)
  • 7.3.5 Russia Virtual Screening for Drug Discovery Market Size and Forecast (2019-2030)
  • 7.3.6 Italy Virtual Screening for Drug Discovery Market Size and Forecast (2019-2030)

8 Asia-Pacific

• 8.1 Asia-Pacific Virtual Screening for Drug Discovery Consumption Value by Type (2019-2030)
• 8.2 Asia-Pacific Virtual Screening for Drug Discovery Consumption Value by Application (2019-2030)
• 8.3 Asia-Pacific Virtual Screening for Drug Discovery Market Size by Region
  • 8.3.1 Asia-Pacific Virtual Screening for Drug Discovery Consumption Value by Region (2019-2030)
  • 8.3.2 China Virtual Screening for Drug Discovery Market Size and Forecast (2019-2030)
  • 8.3.3 Japan Virtual Screening for Drug Discovery Market Size and Forecast (2019-2030)
  • 8.3.4 South Korea Virtual Screening for Drug Discovery Market Size and Forecast (2019-2030)
  • 8.3.5 India Virtual Screening for Drug Discovery Market Size and Forecast (2019-2030)
  • 8.3.6 Southeast Asia Virtual Screening for Drug Discovery Market Size and Forecast (2019-2030)
  • 8.3.7 Australia Virtual Screening for Drug Discovery Market Size and Forecast (2019-2030)

9 South America

• 9.1 South America Virtual Screening for Drug Discovery Consumption Value by Type (2019-2030)
• 9.2 South America Virtual Screening for Drug Discovery Consumption Value by Application (2019-2030)
• 9.3 South America Virtual Screening for Drug Discovery Market Size by Country
  • 9.3.1 South America Virtual Screening for Drug Discovery Consumption Value by Country (2019-2030)
  • 9.3.2 Brazil Virtual Screening for Drug Discovery Market Size and Forecast (2019-2030)
  • 9.3.3 Argentina Virtual Screening for Drug Discovery Market Size and Forecast (2019-2030)

10 Middle East & Africa

• 10.1 Middle East & Africa Virtual Screening for Drug Discovery Consumption Value by Type (2019-2030)
• 10.2 Middle East & Africa Virtual Screening for Drug Discovery Consumption Value by Application (2019-2030)
• 10.3 Middle East & Africa Virtual Screening for Drug Discovery Market Size by Country
  • 10.3.1 Middle East & Africa Virtual Screening for Drug Discovery Consumption Value by Country (2019-2030)
  • 10.3.2 Turkey Virtual Screening for Drug Discovery Market Size and Forecast (2019-2030)
  • 10.3.3 Saudi Arabia Virtual Screening for Drug Discovery Market Size and Forecast (2019-2030)
  • 10.3.4 UAE Virtual Screening for Drug Discovery Market Size and Forecast (2019-2030)

11 Market Dynamics

• 11.1 Virtual Screening for Drug Discovery Market Drivers
• 11.2 Virtual Screening for Drug Discovery Market Restraints
• 11.3 Virtual Screening for Drug Discovery Trends Analysis
• 11.4 Porters Five Forces Analysis
  • 11.4.1 Threat of New Entrants
  • 11.4.2 Bargaining Power of Suppliers
  • 11.4.3 Bargaining Power of Buyers
  • 11.4.4 Threat of Substitutes
  • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

• 12.1 Virtual Screening for Drug Discovery Industry Chain
• 12.2 Virtual Screening for Drug Discovery Upstream Analysis
• 12.3 Virtual Screening for Drug Discovery Midstream Analysis
• 12.4 Virtual Screening for Drug Discovery Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology
• 14.2 Research Process and Data Source